ACVR2A and Glucose intolerance: These findings align with emerging evidence from mice studies suggesting that ActRIIA/IIB blockade may disrupt glucose homeostasis, given that hepatic follistatin production caused glucose intolerance [26] and αActRIIA/IIB treatment caused elevated blood glucose levels in fed mice [16,40], similar to our findings.